Pipeline
Our Pipeline
Relevium Medical is developing a portfolio of novel pharmacological gel candidates for various chronic pain disorders. We are specifically targeting clinical areas that require a multimodal treatment approach.
RM-010 is our most advanced and lead candidate. RM-010 is an injectable hydrogel treatment offering superior, safe, and long lasting pain relief in OA.
RM-020 is administered as a gel acting as a replacement for the damaged bladder lining as well as suppressing the overactive pain-sensing nerves in IC.
RM-030 is a multimodal gel for trauma wound infections - formulated as a broad-spectrum antimicrobial for prophylactic or therapeutic use and with the added benefit of pain reduction.
RM-040 is a hydrogel pain relieving treatment offering superior, and long-lasting effect post-surgery. This treatment will reduce the need for post-op oral medications, including the use of opioids.
RM-010 is our most advanced and lead candidate. RM-010 is an injectable hydrogel treatment offering superior, safe, and long lasting pain relief in OA.
RM-020 is administered as a gel acting as a replacement for the damaged bladder lining as well as suppressing the overactive pain-sensing nerves in IC.
RM-030 is a multimodal gel for trauma wound infections - formulated as a broad-spectrum antimicrobial for prophylactic or therapeutic use and with the added benefit of pain reduction.
RM-040 is a hydrogel pain relieving treatment offering superior, and long-lasting effect post-surgery. This treatment will reduce the need for post-op oral medications, including the use of opioids.